🇺🇸 FDA
Patent

US 8747843

Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 8747843 (Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor) held by The Board of Regents of the University of Texas System expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P17/02